Safety, Tolerability and Efficacy of PresbiDrops (CSF-1) in Presbyopic Subjects
Clinical trial NCT02965664 · COMPLETED
Trial details
- NCT number
- NCT02965664
- Sponsor
- Orasis Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2017-04-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.